Literature DB >> 25037431

pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells.

Hua Guo1, Yuanyuan Liu2, Yan Wang3, Jing Wu4, Xiaoying Yang3, Rongshan Li3, Yinsong Wang5, Ning Zhang6.   

Abstract

Urocanic acid was conjugated to pullulan to synthesize O-urocanyl pullulan (URPA) with degree of substitution (DS) of 8.2%. URPA nanoparticles prepared by dialysis method had spherical shapes and a mean diameter of 156.8 ± 16.8 nm. Adriamycin (ADR) was successfully loaded into URPA nanoparticles and exhibited pH-sensitive in vitro release property. MTT assay showed that ADR-loaded URPA (ADR/URPA) nanoparticles had a significant higher toxicity against drug resistant MCF-7/ADR cells than free ADR, and the reversal index reached up to 9.6. The results of flow cytometry and confocal microscopy showed that URPA nanoparticles efficiently enhanced accumulation and retention of ADR in MCF-7/ADR cells and successfully delivered ADR into cell nucleus. The reversal effect of ADR/URPA nanoparticles on the drug resistance of MCF-7/ADR cells was perhaps related with their cell entry and intracellular drug release mechanisms.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Drug resistance; Nanoparticle carrier; O-Urocanyl pullulan; pH-sensitive

Mesh:

Substances:

Year:  2014        PMID: 25037431     DOI: 10.1016/j.carbpol.2014.05.057

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  6 in total

Review 1.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

2.  Modeling and optimization of nanoemulsion containing Sorafenib for cancer treatment by response surface methodology.

Authors:  Zahra Izadiyan; Mahiran Basri; Hamid Reza Fard Masoumi; Roghayeh Abedi Karjiban; Norazlinaliza Salim; Kamyar Shameli
Journal:  Chem Cent J       Date:  2017-03-02       Impact factor: 4.215

3.  A personalized and long-acting local therapeutic platform combining photothermal therapy and chemotherapy for the treatment of multidrug-resistant colon tumor.

Authors:  Beibei Wang; Sunyi Wu; Zhiqiang Lin; Yajun Jiang; Yan Chen; Zhe-Sheng Chen; Xiaoying Yang; Wei Gao
Journal:  Int J Nanomedicine       Date:  2018-12-10

4.  Exopolysaccharide-Derived Carbon Dots for Microbial Viability Assessment.

Authors:  Fengming Lin; Chengcheng Li; Zhan Chen
Journal:  Front Microbiol       Date:  2018-11-09       Impact factor: 5.640

5.  Entrapment of Hydrophobic Biocides into Cellulose Acetate Nanoparticles by Nanoprecipitation.

Authors:  Cynthia Cordt; Tobias Meckel; Andreas Geissler; Markus Biesalski
Journal:  Nanomaterials (Basel)       Date:  2020-12-07       Impact factor: 5.076

6.  pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer.

Authors:  Sipei Zhang; Nan Guo; Guoyun Wan; Tao Zhang; Chunyu Li; Yongfei Wang; Yinsong Wang; Yuanyuan Liu
Journal:  J Nanobiotechnology       Date:  2019-10-17       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.